Geode Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.7M Buy
2,003,701
+27,040
+1% +$400K ﹤0.01% 1743
2025
Q1
$35.4M Buy
1,976,661
+134,360
+7% +$2.41M ﹤0.01% 1575
2024
Q4
$32.1M Buy
1,842,301
+111,256
+6% +$1.94M ﹤0.01% 1692
2024
Q3
$24.2M Buy
1,731,045
+64,744
+4% +$906K ﹤0.01% 1877
2024
Q2
$13.7M Buy
1,666,301
+105,413
+7% +$867K ﹤0.01% 2133
2024
Q1
$12M Buy
1,560,888
+39,158
+3% +$302K ﹤0.01% 2211
2023
Q4
$13.7M Buy
1,521,730
+81,086
+6% +$729K ﹤0.01% 2149
2023
Q3
$12.9M Buy
1,440,644
+48,888
+4% +$437K ﹤0.01% 2102
2023
Q2
$21.4M Buy
1,391,756
+175,182
+14% +$2.69M ﹤0.01% 1807
2023
Q1
$27.4M Buy
1,216,574
+119,563
+11% +$2.69M ﹤0.01% 1594
2022
Q4
$23.1M Buy
1,097,011
+36,605
+3% +$770K ﹤0.01% 1672
2022
Q3
$26.1M Buy
1,060,406
+35,481
+3% +$874K ﹤0.01% 1543
2022
Q2
$24.8M Sell
1,024,925
-33,977
-3% -$823K ﹤0.01% 1611
2022
Q1
$27.3M Buy
1,058,902
+15,619
+1% +$402K ﹤0.01% 1683
2021
Q4
$32.4M Buy
1,043,283
+59,305
+6% +$1.84M ﹤0.01% 1631
2021
Q3
$23.9M Sell
983,978
-21,461
-2% -$520K ﹤0.01% 1834
2021
Q2
$14.7M Buy
1,005,439
+48,193
+5% +$703K ﹤0.01% 2193
2021
Q1
$23.9M Buy
957,246
+199,385
+26% +$4.98M ﹤0.01% 1757
2020
Q4
$20.7M Buy
757,861
+29,437
+4% +$802K ﹤0.01% 1697
2020
Q3
$13.4M Buy
728,424
+60,764
+9% +$1.12M ﹤0.01% 1781
2020
Q2
$13.6M Buy
667,660
+7,729
+1% +$158K ﹤0.01% 1749
2020
Q1
$9.63M Buy
659,931
+53,074
+9% +$774K ﹤0.01% 1754
2019
Q4
$8.62M Buy
606,857
+18,180
+3% +$258K ﹤0.01% 2115
2019
Q3
$6.82M Sell
588,677
-39,561
-6% -$458K ﹤0.01% 2194
2019
Q2
$12.6M Buy
628,238
+92,800
+17% +$1.86M ﹤0.01% 1774
2019
Q1
$12.1M Buy
535,438
+52,355
+11% +$1.18M ﹤0.01% 1767
2018
Q4
$10.9M Buy
483,083
+24,468
+5% +$554K ﹤0.01% 1728
2018
Q3
$13.2M Buy
458,615
+14,873
+3% +$427K ﹤0.01% 1722
2018
Q2
$12.1M Buy
443,742
+75,659
+21% +$2.06M ﹤0.01% 1730
2018
Q1
$8.23M Buy
368,083
+24,110
+7% +$539K ﹤0.01% 1905
2017
Q4
$7.25M Buy
343,973
+24,615
+8% +$519K ﹤0.01% 1975
2017
Q3
$7.95M Buy
319,358
+5,521
+2% +$137K ﹤0.01% 1895
2017
Q2
$6.09M Sell
313,837
-20,157
-6% -$391K ﹤0.01% 2020
2017
Q1
$6.17M Sell
333,994
-10,220
-3% -$189K ﹤0.01% 1963
2016
Q4
$6.52M Buy
344,214
+68,420
+25% +$1.29M ﹤0.01% 1877
2016
Q3
$6.17M Buy
275,794
+4,989
+2% +$112K ﹤0.01% 1830
2016
Q2
$4.82M Buy
270,805
+8,076
+3% +$144K ﹤0.01% 1939
2016
Q1
$3.59K Buy
262,729
+23,275
+10% +$318 ﹤0.01% 2087
2015
Q4
$4.62M Buy
239,454
+14,773
+7% +$285K ﹤0.01% 1929
2015
Q3
$4.55M Buy
224,681
+3,373
+2% +$68.3K ﹤0.01% 1896
2015
Q2
$7.34M Buy
221,308
+54,507
+33% +$1.81M ﹤0.01% 1634
2015
Q1
$4M Buy
166,801
+37,769
+29% +$905K ﹤0.01% 1996
2014
Q4
$1.58M Buy
129,032
+42,639
+49% +$522K ﹤0.01% 2571
2014
Q3
$779K Buy
86,393
+53,298
+161% +$481K ﹤0.01% 2939
2014
Q2
$388K Buy
33,095
+2,431
+8% +$28.5K ﹤0.01% 3272
2014
Q1
$652K Buy
+30,664
New +$652K ﹤0.01% 3019